(Q31119010)

29 June 2017

1 reference

title

The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy? (English)

1 reference

29 June 2017

Chowdhury TA

1

1 reference

29 June 2017

Hopkins D

series ordinal

2

1 reference

29 June 2017

Dodson PM

series ordinal

3

1 reference

29 June 2017

Vafidis GC

series ordinal

4

1 reference

29 June 2017

publication date

1 November 2002

1 reference

29 June 2017

1 reference

29 June 2017

volume

16

1 reference

29 June 2017

issue

6

1 reference

29 June 2017

page(s)

689-693

1 reference

Incidence of blindness and visual impairment in diabetic patients participating in an ophthalmological control and screening programme

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. A comparison of retinopathy in younger and older onset diabetic persons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

The prevalence of diabetic retinopathy and maculopathy and their risk factors in the non-insulin-treated diabetic patients of an English town

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Factors affecting the migration and growth of endothelial cells from microvessels of bovine retina

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

The role of growth factors in proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

The pathogenesis of edema in diabetic maculopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

TYPES OF EXUDATES IN DIABETIC RETINOPATHY

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Lipemic diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Long-term follow-up of and underlying medical conditions in patients with diabetic exudative maculopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Circulating lipid levels and severity of diabetic retinopathy in type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Low density lipoprotein cholesterol: an association with the severity of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

High serum lipoprotein(a) levels in Korean type 2 diabetic patients with proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Influence of serum lipid fractions on the course of diabetic macular edema after photocoagulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Carbohydrate-rich, fat-poor diet in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Diabetic retinopathy: different risk factors for exudates and haemorrhages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Risk of macular degeneration in users of statins: cross sectional study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Long-term visual results after laser photocoagulation for diabetic maculopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Long term effectiveness of photocoagulation for diabetic maculopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Effect of danaparoid sodium on hard exudates in diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Effect of calcium dobesilate on progression of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Partial absorption of hard exudates in patients with diabetic end-stage renal disease and severe anemia after treatment with erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Reduction of retinal exudates in diabetic retinopathy after heparin-induced extracorporal LDL-precipitation (HELP). A case report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

A three-year trial of atromid therapy in exudative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

The effects of lipid lowering on diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700205

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6700205

1 reference

Dimensions Publication ID

29 June 2017

1031503583

0 references

1 reference